Announcements Trials
Browse Landscape

Status

Recruiting 4Completed 1

Sponsor Class

INDUSTRY 4OTHER 1

Study Type

Interventional 34Observational 5Expanded_access 1

Sponsor

Cancer Type

Genitourinary 5

Conditions

Breast Neoplasms 693Neoplasms 610Prostatic Neoplasms 320Lung Neoplasms 309Colorectal Neoplasms 281Carcinoma, Non-Small-Cell Lung 253Pancreatic Neoplasms 178Carcinoma, Hepatocellular 169Stomach Neoplasms 143Multiple Myeloma 127Ovarian Neoplasms 121Melanoma 116Colonic Neoplasms 114Brain Neoplasms 108Hematologic Neoplasms 106Head and Neck Neoplasms 103Urinary Bladder Neoplasms 102Leukemia, Myeloid, Acute 100Esophageal Neoplasms 100Disease 97Liver Neoplasms 92Uterine Cervical Neoplasms 90Neoplasm Metastasis 89Lymphoma 86Rectal Neoplasms 85Precursor Cell Lymphoblastic Leukemia-Lymphoma 82Endometrial Neoplasms 78Carcinoma, Renal Cell 74Leukemia 65Sarcoma 63

Interventions

radium Ra 223 dichloride 1Pluvicto 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Observational × Metastatic Castration-resistant Prostate Cancer × 1 year × Clear all
NCT06031805 2026-04-27

PROWESs

AstraZeneca

Recruiting
300 enrolled
Genitourinary

Metastatic Castration-resistant Prostate Cancer

NCT06242509 2026-04-27

AkkPRO

Assistance Publique - Hôpitaux de Paris

Recruiting
52 enrolled
Genitourinary

Metastatic Castration-resistant Prostate Cancer

NCT06514521 2025-12-30

Post Marketing Study on Pluvicto in Korea

Novartis

Recruiting
278 enrolled
Genitourinary

Metastatic Castration-resistant Prostate Cancer

NCT06380738 2025-12-26

PROceed

AstraZeneca

Recruiting
250 enrolled
Genitourinary

Metastatic Castration-resistant Prostate Cancer

NCT02141438 2025-10-16

REASSURE

Bayer

Completed
1,472 enrolled 18 charts
Genitourinary

Metastatic Castration-resistant Prostate Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡